Earnings History Data for Ensysce Biosciences (ENSC) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Ensysce Biosciences
Ensysce Biosciences is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is involved in developing tamper-proof opioids which prevent both drug abuse and overdoses. Ensysce Biosciences, formerly known as Leisure Acquisition Corp., is based in SAN DIEGO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | AH | ENSC | Ensysce Biosciences | 6.00 | 0.07 | -0.30 | 0.00 | Ensysce Biosciences GAAP EPS of $0.07 beats by $0.24 [11/12/2024 5:51 PM] |
0.7115 | 0.04 (5.47%) |
0.78 | 0.11 (15.62%) |
0.14 - 2.06 | 7,599,382 | 82,850,000 | 9,709,517 | ||
| 14-08-2024 | AH | ENSC | Ensysce Biosciences | 3.00 | -0.22 | -0.39 | 0.00 | Ensysce Biosciences GAAP EPS of -$0.22 beats by $0.11 [8/15/2024 12:18 PM] |
0.3999 | 0.01 (2.51%) |
0.40 | 0.01 (2.54%) |
0.36 - 2.06 | 193,232 | 90,000 | 3,673 | ||
| 15-03-2024 | PM | ENSC | Ensysce Biosciences | 2.00 | -1.13 | -0.86 | 0.00 | Ensysce Biosciences reports Q4 results [3/15/2024 10:26 AM] |
0.7915 | 0.04 (5.53%) |
0.74 | -0.01 (-1.83%) |
0.72 - 8.90 | 223,160 | 250,000 | 3,825 | ||
| 09-11-2023 | AH | ENSC | Ensysce Biosciences | 3.00 | -0.87 | -1.06 | 0.00 | Ensysce Biosciences reports Q3 results [11/10/2023 10:17 AM] |
0.8142 | -0.04 (-4.22%) |
0.85 | 0.0 (0.47%) |
0.81 - 56.52 | 43,187 | 50,000 | 3,465 | ||
| 15-05-2023 | PM | ENSC | Ensysce Biosciences | 4.00 | -2.08 | -13.91 | 0.00 | Ensysce Biosciences GAAP EPS of -$2.08 beats by $8.81 [5/16/2023 3:49 AM] |
2.96 | -0.12 (-3.73%) |
3.00 | -0.08 (-2.60%) |
2.82 - 220.80 | 78,950 | 3,180,000 | 4,511 | ||
| 30-03-2023 | PM | ENSC | Ensysce Biosciences, Inc. | 8.07 | -1.52 | -2.59 | 9.00 | Ensysce Biosciences GAAP EPS of -$1.52 beats by $0.89, revenue of $1.43M misses by $0.11M [3/31/2023 12:35 AM] |
4.86 | -1.93 (-28.43%) |
6.25 | -0.54 (-7.96%) |
4.68 - 396.00 | 175,113 | 90,000 | 9,778 | ||
| 14-11-2022 | PM | ENSC | Ensysce Biosciences | 4.00 | -5.13 | -3.00 | 0.00 | Ensysce Biosciences GAAP EPS of -$5.13 [11/15/2022 9:09 AM] |
2.15 | -0.22 (-9.28%) |
2.35 | -0.02 (-0.84%) |
1.90 - 140.00 | 626,436 | 1,100,000 | 35,881 | ||
|
||||||||||||||||||
| 11-08-2022 | AH | ENSC | Ensysce Biosciences | 19.00 | -0.24 | -0.21 | 0.00 | Ensysce Biosciences GAAP EPS of -$0.24, revenue of $0.2M [8/11/2022 5:34 PM] |
0.4807 | -0.02 (-4.36%) |
0.50 | 0.0 (-0.52%) |
0.39 - 7.00 | 522,149 | 540,000 | 3,137 | ||
| 31-03-2022 | AH | ENSC | Ensysce Biosciences, Inc. | 26.20 | -0.45 | 0.09 | 0.00 | Ensysce Biosciences reports Q4 results [3/31/2022 5:16 PM] |
1.10 | -0.04 (-3.51%) |
1.06 | -0.08 (-7.02%) |
0.87 - 17.12 | 346,709 | 450,000 | 53,411 | ||